Product Details for: Rethymic

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
For Suspension
Implantation
SEMI-QUANTITATIVE
Dish
351(a)
Rethymic
Rx
Proper Name
allogeneic processed thymus tissue-agdc
BLA Number
125685
Applicant
Sumitomo Pharma America, Inc.
Original Approval Date
October 8, 2021
Date of First Licensure
8-Oct-21
RETURN TO SEARCH RESULTS